A B S T R A C T The toxic effects associated with rapid lipid mobilization and a high plasma free fatty acid (FFA) concentration produced by glucagon were evaluated. Glucagon (0.5 mg/kg of body wt) was injected intravenously into nonfasting geese. The geese developed rapid respirations and high plasma FFA levels within 15 min after the glucagon injection; three of eleven died. Control geese, injected with saline, did not exhibit toxic signs. Peak FFA concentrations developed 15 min after glucagon and high levels persisted for over 90 min. Geese injected with glucagon frequently developed electrocardiographic abnormalities that included supraventricular tachycardia, premature ventricular contractions, and signs of myocardial ischemia. Light and electron microscopy revealed acute myocardial degeneration and fatty infiltration of the liver. The increase in plasma FFA concentrations and toxic effects were not prevented by pretreatment with nicotinic acid or propranolol.
INTRODUCTION
Acute mobilization of lipid which results in high plasma free fatty acid (FFA) concentrations has been associated with toxic effects in dogs 1 and rabbits (2) . Long chain fatty acids are known to produce cytotoxic effects in tissue cultures (3) and cause acute myocardial failure when injected intravenously in the unbound state into dogs (4) . Infusion of norepinephrine has been associated with the development of fatty liver (5) and acute myocardial necrosis in dogs (6, 7) . These effects in dogs can be prevented by propranolol that inhibits the usual increase in FFA produced by catecholamines. 1 Birds mobilize lipid to a lesser extent in response to catecholamines or pituitary hormones (8, 9) than do mammals, but develop a prompt increase in FFA after injections of glucagon (10) . Lipolysis in pigeon adipose tissue in vitro was stimulated by epinephrine and glucagon (11 ) .
In this experiment, the biochemical and morphological effects of acute lipid mobilization produced by glucagon were studied in the goose (Aniser domesticus). METHODS Healthy, nonfasting geese of both sexes, weighing 2.5-7 kg were used. In group I, 11 geese were used. Under local 1 % lidocaine anesthesia, an incision was made in the neck and the jugular vein was exposed and used for intravenous injections and blood sampling. After an initial blood sample was taken, glucagon 2 0.5 mg/kg was given intravenously. Additional blood samples were taken 15, 30, 60, and 90 min for plasma FFA, blood glucose, and serum triglyceride determinations. Serum glutamic oxalacetic transaminase and lactic dehydrogenase activities were measured in four control and seven glucagon-treated geese. Electrocardiograms were taken on representative geese in all groups at intervals during the experiments. At the end of 90 min, all geese in group I were killed with pentobarbital. Samples of tissue were In an attempt to inhibit the effects of glucagon, six geese were treated with nicotinic acid (group V) before they were given glucagon 30 min later. Two geese received nicotinic acid, 25 mg/kg by intraperitoneal injection; two others received the same dose intravenously, and two were given 50 mg/kg intravenously. Five geese were treated with propranolol, (group VI) 2 mg/kg, intravenously, 15 min before they were given glucagon. Geese in groups V and VI were killed 90 min after they received glucagon. At 60 min, supraventricular tachycardia was present.
By 90 min the rate had slowed, but the bizarre complexes suggested a ventricular rhythm or aberrant condution with supraventricular arrhythemia. The goose died shortly after the last tracing was taken. 
RESULTS
Within 10 min after the geese were injected with glucagon, toxic signs developed. Characteristic toxic signs included tachycardia, rapid respirations, vomiting, defecation, and prostration. Some geese exhibited progressive deterioration and died within 90 min. The mortality figures are shown in Table I . In contrast, control birds did not exhibit toxic signs and none died.
Glucagon produced a threefold increase in FFA within 15 min (Fig. 1) . Mean FFA values increased from 873 to 2611 ,uEq/liter and remained elevated for the rest of the experiment. A simul-U.
< -4 - taneous increase in blood glucose also occurred. Nicotinic acid did not prevent the rise in FFA induced by glucagon (Table II) . Geese treated with propranolol before receiving glucagon developed even higher FFA levels than those given glucagon alone. Neither nicotinic acid nor propranolol inhibited the adipokinetic influence or the toxic effects that resulted from the injection of glucagon.
Geese, given glucagon, developed electrocardiographic changes frequently. An example is shown in Fig. 2 . Sinus tachycardia and premature ventricular contractions were common. In others, sinus arrest, supraventricular tachycardia, ventricular tachycardia, and signs of myocardial ischemia were observed. In group III, 6 , , F I G U R E 5 --. glucagon-treated geese (group I) from 115 ±-31 to 182 +52 mg/100 ml at 90 min whereas the control values (group II) decreased from 176 ± 100 to 119 ±68. None of the changes in triglyceride concentrations were statistically significant. Although 6 of the 22 geese given glucagon died within 90 min after the injection, myocardial lesions were found in only two. Twelve in this group had fatty livers. In contrast, 6 of 10 geese allowed to survive for 24 hr after receiving glucagon had myocardial lesions at necropsy. In the latter group, eight had fatty infiltration of the liver and one had acute hepatic necrosis.
The typical myocardial lesion on gross examination consisted of a focal hemorrhagic area that was usually found in the ventricular wall. On histological examination areas of focal hemorrhage were seen. In one of the myocardial lesions from a goose in group III (Fig. 3) , leukocytic infiltration and focal areas of early myocardial necrosis were conspicuous features. Small fat droplets were present in the lesion when the sections were stained with Oil Red 0. Examination of the cardiac lesions with electron microscopy revealed destructive changes in the myofibrils, distortion of mitochondrial structure, and osmiophilic intramitochondrial inclusions in addition to the changes observed with light microscopy (Figs. 4 and 5 ). An electron micrograph demonstrating myocardium from a normal goose is shown in Fig. 6 .
Hepatic changes seen in the glucagon-treated geese consisted chiefly of fatty infiltration that was presented grossly as a yellowish-tan liver. Histologically, lipid vacuoles were seen in the hematoxylin and eosin stained specimens of liver (Fig. 7 B) . These areas took up a stain for lipid, Oil Red 0, which is shown in Fig. 7 C. Electron microscopy confirmed the changes seen with light microscopy (Fig. 7 A) . In one goose in group III, hepatic necrosis was found in addition to the fatty infiltration. Electron micrographs and photomicrographs of normal goose liver are shown in Fig. 8 A, (17) .
The greater proportion of FFA mobilized from adipose tissue is taken tip in liver and muscle. After injection of labeled albumin-bound palmitic acid-I-114C, about one-third of the recovered activity was found in the liver and one-third in muscle ( 18, 19) . In man, a significant arteriovenous difference of FFA has been found across the myocardium, indicating uptake of FFA (20) . The mechanisms involved in the uptake of FFA in various organs have not been clearly delineated. It appears that the uptake was proportional to the amount of FFA perfusing an organ per unit time (plasma concentration times flow) (17) .
Since FFA appears to be taken up by various organs in amounts proportional to the concentration in plasma, increased lipid mobilization will cause increased uptake of FFA in various target organs. If this results in a concentration of FFA greater than the oxidative needs of the cells, either storage or increased oxidation of the fatty acids may have an important influence on metabolism, since fatty acids uncouple oxidative phosphorylation in vitro (21) .
Agents stimulating lipid mobilization increase the lipid content of the liver. Thus, administration of epinephrine (22) livers. The glucagon-treated geese also developed increased serum glutamic oxalacetic transaminase and lactic dehydrogenase activities. Serum triglyceride concentrations increased slightly in the glucagon group and decreased in the control geese.
The myocardial lesion produced by glucagon was similar or identical to that produced in dogs by norepinephrine 1 or in rabbits by injections of ACTH (27) . All of these agents were potent stimuli for lipid mobilization in the particular species used. Electron microscopy revealed extensive destruction of myofibrils and mitochondria. Distorted, but intact mitochondria were frequently found to have osmiophilic inclusions.
Fatty liver was also a common finding in the geese given glucagon. Hepatic necrosis was found in one bird 24 hr after glucagon. Extensive lipid was demonstrated by staining methods, and electron microscopy revealed extensive vacuolization of the hepatic cells.
The dose of glucagon used in this study was pharmacologic, and produced a potent lipid mobilizing effect. In most instances, when glucagon was given to normal human subjects, an immediate depression of plasma FFA occurred followed by a later rise (28, 29) . The effect was much less, however, than the large change we observed in geese. In an in vitro study, using human adipose tissue obtained at operation, glucagon produced little or no lipolytic effect (30) . In different species, glucagon has been shown to stimulate FFA release in vitro (31, 32) .
The relevance of these observations to clinical disease is speculative, but similar mechanisms may operate in the pathogenesis of myocardial and hepatic disorders. The hypothesis that very high plasma concentrations of FFA or a decrease in the rate of oxidation of fatty acids by the cell may result in accumulation of sufficient fatty acids to prove detrimental to cellular structure and function is an interesting concept. Diphtheria toxin produced acute myocardial lesions similar to those induced by catecholamines (6) . This toxin also inhibited the oxidation of long chain fatty acids by heart homogenate preparations (33) .
Significant elevation of plasma FFA concentrations were found in patients with acute myocardial infarction and cerebral vascular occlusion (34) . More recently, patients with serum FFA concentrations above 1200 FuEq/liter after acute myocardial infarction had an increased prevalence of serious arrhythmias and a higher mortality (35) .
It is unknown whether fatty acids play a causative role or whether they merely reflect other metabolic or hormonal changes in patients with acute myocardial infarction. Such a differentiation is of considerable importance, since means are available for lowering plasma FFA concentrations in man.
